Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their Caregivers



Status:Completed
Conditions:Anxiety, Lung Cancer, Cancer, Cancer
Therapuetic Areas:Oncology, Psychiatry / Psychology
Healthy:No
Age Range:Any
Updated:5/5/2014
Start Date:November 2012
End Date:June 2014

Use our guide to learn which trials are right for you!

Intervention Development for Anxiety in Metastatic NSCLC Patients and Their Caregivers

This pilot clinical trial studies cognitive behavioral therapy in treating anxiety in
patients with stage IV non-small cell lung cancer and their caregivers. Cognitive behavioral
therapy may reduce anxiety and improve the well-being and quality of life of patients who
have stage IV non-small cell lung cancer and their caregivers.

PRIMARY OBJECTIVES:

I. To identify, through both quantitative and qualitative methods, clinical correlates of
anxiety and points of intervention to reduce anxiety in patients with late-stage lung cancer
and their primary caregivers.

II. To apply these findings to develop a brief dyadic intervention based on Cognitive
Behavioral Therapy (CBT) to reduce anxiety in late-stage lung cancer patients and their
primary caregivers.

III. To evaluate the feasibility and acceptability of the pilot intervention through number
of completed visits and assessment pre- and post- intervention.

OUTLINE:

Participants undergo cognitive behavioral therapy over 1 hour once weekly for a total of 6
sessions. Sessions are tailored to patient and caregiver cognitions and approach and
avoidance behaviors.

After completion of study treatment, participants are followed up at 1 week.

Inclusion Criteria:

- Diagnosis of stage IV non-small cell lung cancer

- At least 6 weeks post-diagnosis

- Current symptoms of anxiety (e.g., Hamilton Rating Scale for Anxiety [HAM-A] >=14)

- Ability to understand and the willingness to sign a written informed consent document

- CAREGIVER: Identified by patient as primary caregiver

- CAREGIVER: At least 14 hours/week spent caring for patient

- CAREGIVER: Current symptoms of anxiety (e.g., HAM-A >= 14)

- CAREGIVER: Ability to understand and the willingness to sign a written informed
consent document

Exclusion Criteria:

- PATIENTS AND CAREGIVERS:

- Active, unstable, untreated serious mental illness

- Other cognitive inability to complete informed consent process or study procedures
We found this trial at
1
site
450 Serra Mall
Stanford, California 94305
(650) 723-2300
Stanford University Stanford University, located between San Francisco and San Jose in the heart of...
?
mi
from
Stanford, CA
Click here to add this to my saved trials